tiprankstipranks
Trending News
More News >
Orchestra Biomed Holdings, Inc. (OBIO)
:OBIO
US Market

Orchestra BioMed Holdings (OBIO) Financial Statements

Compare
63 Followers

Orchestra BioMed Holdings Financial Overview

Orchestra BioMed Holdings's market cap is currently $104.21M. The company's EPS TTM is $-0.49; its P/E ratio is ―; Orchestra BioMed Holdings is scheduled to report earnings on May 12, 2025, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 2.64M$ 2.76M$ 3.53M$ -782.00K$ 5.70M
Gross Profit$ 2.43M$ 2.57M$ 3.21M$ -981.00K$ 5.56M
Operating Income$ -64.30M$ -51.51M$ -32.66M$ -21.80M$ -18.75M
EBITDA$ -64.30M$ -51.22M$ -32.44M$ -21.62M$ -18.61M
Net Income$ -61.02M$ -49.12M$ -33.61M$ -23.01M$ -21.36M
Balance Sheet
Cash & Short-Term Investments$ 66.81M$ 87.59M$ 83.78M$ 10.90M$ 35.79M
Total Assets$ 76.17M$ 95.21M$ 95.57M$ 13.53M$ 38.09M
Total Debt$ 16.53M$ 1.69M$ 11.87M$ 5.67M$ 9.46M
Net Debt$ -5.73M$ -28.87M$ -7.91M$ -4.26M$ -10.89M
Total Liabilities$ 43.22M$ 27.17M$ 43.04M$ 84.76M$ 86.63M
Stockholders' Equity$ 32.96M$ 68.04M$ 52.53M$ -71.23M$ -48.54M
Cash Flow
Free Cash Flow$ -50.85M$ -46.20M$ -29.88M$ -19.70M$ -26.72M
Operating Cash Flow$ -50.56M$ -46.13M$ -29.29M$ -19.43M$ -26.18M
Investing Cash Flow$ 13.09M$ 10.69M$ -64.12M$ 13.02M$ 26.97M
Financing Cash Flow$ 29.17M$ 46.22M$ 103.26M$ -3.99M$ 10.00M
Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History

Orchestra BioMed Holdings Debt to Assets

Orchestra BioMed Holdings Cash Flow

Orchestra BioMed Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis